MicroTech Medical (Hangzhou) Co., Ltd. Class H
HHKEX:22356.79
HKD
-0.11
(-1.59%)
ISIN
CNE100004QN6
Return %
Stock
S&P 500
1Y
-4.50
14.20
3Y
58.64
81.12
5Y
-77.81
68.34
Capital Structure
CNY
•
in mil. unless spec.Working Capital
CNY
•
in mil. unless spec.Growth Rates
CNY
•
in mil. unless spec.Semi-annual Revenue
CNY
•
in mil. unless spec.Semi-annual Earnings Per Share
CNY
•
in mil. unless spec.Semi-annual Dividends Per Share
CNY
•
in mil. unless spec.Company Description
- CEO
- Pan Zheng
- Full Time Employees
- 664
- Sector
- Electronic technology
- Industry
- Electronic equipment/Instruments
- Address
- No. 108 Liuze Street Hangzhou ZH China
- IPO Date
- Oct 19, 2021
- Website
- microtechmd.com
- Similar Companies
- Business
- MicroTech Medical (Hangzhou) Co., Ltd. specializes in the research, development, manufacturing, and marketing of advanced medical devices primarily for the gastrointestinal, pulmonary, and cardiovascular fields. Its core products include endoscopic devices such as surgical endoscopes, ultrasonic scalpels, biopsy forceps, injection needles, snares, and various minimally invasive surgical instruments. The company also develops related imaging systems and accessories utilized in diagnostic and therapeutic procedures. MicroTech Medical operates extensively across China and has expanded its presence into international markets, focusing on hospitals and healthcare providers seeking innovative endoscopic solutions. Founded in 2004 and headquartered in Hangzhou, China, the company has recently strengthened its strategic development by launching new product lines in the endoscopic submucosal dissection (ESD) and endoscopic mucosal resection (EMR) segments, aiming at enhanced minimally invasive treatment options. It has also pursued partnerships and collaborations to accelerate technological advancements and expand its global footprint, including recent updates to its product portfolio emphasizing digital integration and intelligent medical devices. These efforts support its growth in high-demand regions and markets, reinforcing its position within the medical technology industry. MicroTech Medical operates within the medical devices industry, servicing hospitals, specialty clinics, and medical practitioners worldwide. The company’s recent initiatives include expanding research collaborations and investment in innovative medical technologies, reflecting a strategic focus on both product diversification and enhanced market penetration. It maintains a competitive edge through continuous innovation in minimally invasive treatment devices and an expanding range of endoscopic tools aligned with global healthcare trends. The company remains a key player under the ticker 2235.HK, committed to delivering cutting-edge medical solutions to improve patient outcomes.